Seeking Alpha

Goldman Sachs removes Baxter International (BAX) from its Conviction Buy List after finding...

Goldman Sachs removes Baxter International (BAX) from its Conviction Buy List after finding better opportunities in the healthcare sector. Analysts with the firm maintain their Buy rating, while clipping the price target on shares by a $1 to $59. Shares +0.4% premarket.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)